Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 156 of 641 · 7,691 filings

  • Everspin Technologies (MRAM) FY2025 10-K risk factors
    29 risks5 new3 dropped6 reworded

    Everspin Technologies updated its financials, reporting 2025 revenue of $55.2 million and $44.5 million in cash, up from 2024 figures. New risks center on tax law changes, trade policies, tariffs, and potential equity dilution or credit issues.

    Filed Mar 04, 2026
  • Microvision (MVIS) FY2025 10-K risk factors
    31 risks3 new2 dropped10 reworded

    MicroVision secured new financing via $43M convertible notes with bank account collateral. The company faces a Nasdaq minimum bid price deficiency warning. Recent acquisitions include Scantinel Photonics and Luminar Technologies assets.

    Filed Mar 04, 2026
  • Niagen Bioscience (NAGE) FY2025 10-K risk factors
    49 risks1 new1 dropped7 reworded

    Payment processing and HSA/FSA compliance risks were added to operations.

    Filed Mar 04, 2026
  • Nacco Industries (NC) FY2025 10-K risk factors
    31 risks4 new2 dropped13 reworded

    Solar tax-policy changes threaten ReGen projects, including $8.4 million of capitalized solar assets.

    Filed Mar 04, 2026
  • Nine Energy Service (NINE) FY2025 10-K risk factors
    59 risks23 new8 dropped9 reworded

    Nine Energy Service filed for Chapter 11 bankruptcy, wiping out common stock for zero consideration under a confirmed prepackaged plan.

    Filed Mar 04, 2026
  • NN (NNBR) FY2025 10-K risk factors
    35 risks8 new2 dropped12 reworded

    Increased focus on liquidity risks with $159.5 million in debt and tax refund delays from CARES Act provisions.

    Filed Mar 04, 2026
  • OmniAb (OABI) FY2025 10-K risk factors
    65 risks1 new1 dropped11 reworded

    Revenue fell from $26.4 million to $18.7 million, while net losses widened from $62.0 million to $64.8 million.

    Filed Mar 04, 2026
  • Ocugen (OCGN) FY2025 10-K risk factors
    74 risks8 new12 dropped21 reworded

    Added debt agreements with Avenue Capital and EB-5 Life Sciences totaling $30.0 million in principal.

    Filed Mar 04, 2026
  • Oil States International (OIS) FY2025 10-K risk factors
    29 risks1 new1 dropped10 reworded

    Oil States International faces expanded regulatory risks concerning hydraulic fracturing and seismicity across domestic and international jurisdictions. The company updated financial disclosures reflecting changes in asset valuations, tax rules, and tariff impacts from Chinese steel imports.

    Filed Mar 04, 2026
  • Orion Group Holdings (ORN) FY2025 10-K risk factors
    35 risks5 new9 reworded

    Orion Group Holdings highlights new risks from its February 2026 JEM acquisition and variable interest rate exposure. Concrete segment revenue contribution shifted to 36.1% for 2025.

    Filed Mar 04, 2026
  • Octave Specialty Group (OSG) FY2025 10-K risk factors
    42 risks15 new31 dropped14 reworded

    Octave Specialty Group expanded its risk disclosures around catastrophic event exposures, capital requirements, and broker dependencies following recent acquisitions.

    Filed Mar 04, 2026
  • PepGen (PEPG) FY2025 10-K risk factors
    112 risks11 new11 dropped30 reworded

    PepGen faces heightened cash concerns, requiring funding past the 2026 FREEDOM2 data readouts, while narrowing focus to PGN-EDODM1.

    Filed Mar 04, 2026

Companies covered

4,011 companies

371 more under A